The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Barlow David S since 2006.
The trader's CIK number is 1299065.
At the time of the last reporting, Barlow David S was the Director of Molecular Insight Pharmaceuticals, Inc.. (stock ticker symbol MIPI).
Also see all insider trading activities at Molecular Insight Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | NRPH | 0 | $0 | 10,000 | $548,310 | 10,000 | $33,350 |
| 2006 | NRPH | 0 | $0 | 20,000 | $798,660 | 20,000 | $66,700 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | MIPI | 0 | $0 | 97,000 | $16,031 | 0 | $0 |
| 2010 | MIPI | 0 | $0 | 209,800 | $60,744 | 0 | $0 |
| 2009 | MIPI | 0 | $0 | 27,300 | $63,700 | 0 | $0 |
| 2008 | MIPI | 0 | $0 | 0 | $0 | 81,249 | $292,496 |
| 2007 | MIPI | 20,000 | $143,920 | 0 | $0 | 75,001 | $270,003 |
1. New River Pharmaceuticals Inc (NRPH)
2. Molecular Insight Pharmaceuticals, Inc. (MIPI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-01-03 | NRPH | Sale | 10,000 | 54.83 | 548,310 |
| 2007-01-03 | NRPH | Option Ex | 10,000 | 3.33 | 33,350 |
| 2006-12-01 | NRPH | Sale | 10,000 | 49.01 | 490,090 |
| 2006-12-01 | NRPH | Option Ex | 10,000 | 3.33 | 33,350 |
| 2006-03-20 | NRPH | Option Ex | 10,000 | 3.33 | 33,350 |
| 2006-03-20 | NRPH | Sale | 10,000 | 30.86 | 308,570 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-01-27 | MIPI | Sale | 38,000 | .17 | 6,650 |
| 2011-01-28 | MIPI | Sale | 59,000 | .16 | 9,381 |
| 2010-12-17 | MIPI | Sale | 155,000 | .20 | 31,000 |
| 2010-12-16 | MIPI | Sale | 45,000 | .22 | 9,900 |
| 2010-01-12 | MIPI | Sale | 4,000 | 2.08 | 8,308 |
| 2010-01-14 | MIPI | Sale | 5,800 | 1.99 | 11,536 |
| 2009-12-18 | MIPI | Sale | 5,500 | 2.25 | 12,402 |
| 2009-12-21 | MIPI | Sale | 6,300 | 2.33 | 14,704 |
| 2009-12-23 | MIPI | Sale | 13,500 | 2.36 | 31,914 |
| 2009-12-24 | MIPI | Sale | 2,000 | 2.34 | 4,680 |
| 2008-12-29 | MIPI | Option Ex | 81,249 | 3.60 | 292,496 |
| 2007-11-30 | MIPI | Buy | 5,000 | 8.47 | 42,355 |
| 2007-11-20 | MIPI | Buy | 15,000 | 6.77 | 101,565 |
| 2007-11-08 | MIPI | Option Ex | 75,001 | 3.60 | 270,003 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Barlow David S (Director of Molecular Insight Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.